When you’re looking for solutions to improve your intimate function, it’s easy to get overwhelmed by the vast array of ...

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in ...

The American Lung Association is launching a new campaign to support and empower individuals living with chronic obstructive ...

Sometimes the realization is slow even on the part of their healthcare professionals. While patients modify their lives around emphysema, professionals, too, fall within a certain lassitude in the ...

Pulmonary arterial hypertension (PAH) represents a complex disease with multifaceted pathophysiology involving over 20 identified genetic mutations that can contribute to disease development.

Find out how treatments like medicine, oxygen therapy, and pulmonary therapy can help you feel better and breathe easier if you have moderate-to-severe chronic obstructive pulmonary disease (COPD).

For nearly 16 million Americans, living with chronic obstructive pulmonary disease (COPD) is a difficult reality. The progressive disease limits air flow to the lungs and causes breathing problems.

When spirometry is unavailable, physicians can use the St. George’s Respiratory Questionnaire score plus peak expiratory flow to screen for COPD, according to data published in American Journal ...

Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of ...

Chronic obstructive pulmonary disease (COPD) is a prevalent chronic airway inflammatory condition characterised by significant heterogeneity and has emerged as one of the leading causes of mortality ...

The most common genetic causes of central conducting lymphatic anomaly are RASopathies with pathogenic variants upregulating the RAS/MAPK signalling pathway. Variants in PIEZO1 are associated with ...

COPD causes progressive lung function decline and is the third leading cause of death worldwide. In a pair of Phase III studies, treatment with Dupixent elicited a 30% and 34% reduction in the ...